Market Overview

Why Oragenics Stock Is Trading Higher Today

Why Oragenics Stock Is Trading Higher Today

Oragenics (NYSE: OGEN) shares are trading higher on Friday after the company discontinued its AG013 oral mucositis development program and said it will use available cash to continue the development of its TerraCoV2 coronavirus vaccine candidate.

Oragenics is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis.

Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering.

Oragenics shares were trading up 32.57% at $1.28 at the time of publication on Friday. The stock has a 52-week high of $1.32 and a 52-week low of 35 cents.


Related Articles (OGEN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Health Care Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at